These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30827473)

  • 21. Peak expiratory flow as a surrogate for health related quality of life in chronic obstructive pulmonary disease: a preliminary cross sectional study.
    Obaseki DO; Akanbi MO; Onyedum CC; Ozoh OB; Jumbo J; Akor AA; Erhabor GE
    Ghana Med J; 2014 Jun; 48(2):85-90. PubMed ID: 25667555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ambient temperature on lung function in patients with chronic obstructive pulmonary disease: A time-series panel study.
    Lin Z; Gu Y; Liu C; Song Y; Bai C; Chen R; Chen S; Kan H
    Sci Total Environ; 2018 Apr; 619-620():360-365. PubMed ID: 29156256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?
    Leidy NK; Martinez FJ; Malley KG; Mannino DM; Han MK; Bacci ED; Brown RW; Houfek JF; Labaki WW; Make BJ; Meldrum CA; Quezada W; Rennard S; Thomashow B; Yawn BP
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1901-1912. PubMed ID: 29942123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.
    Jithoo A; Enright PL; Burney P; Buist AS; Bateman ED; Tan WC; Studnicka M; Mejza F; Gillespie S; Vollmer WM;
    Eur Respir J; 2013 Mar; 41(3):548-55. PubMed ID: 22743668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exacerbations in Chronic Obstructive Pulmonary Disease: Identification and Prediction Using a Digital Health System.
    Shah SA; Velardo C; Farmer A; Tarassenko L
    J Med Internet Res; 2017 Mar; 19(3):e69. PubMed ID: 28270380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population.
    Nelson SB; LaVange LM; Nie Y; Walsh JW; Enright PL; Martinez FJ; Mannino DM; Thomashow BM
    Chest; 2012 Aug; 142(2):358-366. PubMed ID: 22194590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peak flow as a predictor of cause-specific mortality in China: results from a 15-year prospective study of ~170,000 men.
    Smith M; Zhou M; Wang L; Peto R; Yang G; Chen Z
    Int J Epidemiol; 2013 Jun; 42(3):803-15. PubMed ID: 23918851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).
    Mackay AJ; Donaldson GC; Patel AR; Singh R; Kowlessar B; Wedzicha JA
    Eur Respir J; 2014 Mar; 43(3):735-44. PubMed ID: 23988767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?
    Thiadens HA; De Bock GH; Van Houwelingen JC; Dekker FW; De Waal MW; Springer MP; Postma DS
    Thorax; 1999 Dec; 54(12):1055-60. PubMed ID: 10567623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory muscle strength during and after hospitalization for COPD exacerbation.
    Mesquita R; Donária L; Genz IC; Pitta F; Probst VS
    Respir Care; 2013 Dec; 58(12):2142-9. PubMed ID: 23716708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
    Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
    Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.
    Quezada WA; Whippo BA; Jellen PA; Leidy NK; Mannino DM; Kim KJ; Han MK; Houfek JF; Make B; Malley KG; Meldrum CA; Rennard SI; Yawn BP; Martinez FJ; Thomashow BM;
    Chest; 2017 Oct; 152(4):761-770. PubMed ID: 28414029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
    Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
    Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of change in physical activity during moderate-to-severe COPD exacerbation.
    Esteban C; Quintana JM; Garcia-Gutierrez S; Anton-Ladislao A; Gonzalez N; Baré M; Fernández de Larrea N; Rivas-Ruiz F;
    Int J Chron Obstruct Pulmon Dis; 2016; 11():251-61. PubMed ID: 26893555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.